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Abstract
Three new 2-pyrral amino acid Schiff base palladium (II) complexes were synthesized, characterized and their activity against 
six bacterial species was investigated. The ligands: Potassium 2-pyrrolidine-L-methioninate (L1), Potassium 2-pyrroli-
dine-L-histidinate (L2) and Potassium 2-pyrrolidine-L-tryptophanate (L3) were synthesized and reacted with dichloro(1,5-
cyclooctadiene)palladium(II) to form new palladium (II) complexes C1, C2 and C3, respectively. 1H NMR, FTIR, UV–Vis, 
elemental analysis and conductivity measurements were used to characterize the products. The antibacterial activities of the 
compounds were evaluated against Gram-positive Staphylococcus aureus (S. aureus, ATCC 25923), methicillin-resistant 
Staphylococcus aureus (MRSA, ATCC 33591), Staphylococcus epidermidis (S. epidermidis, ATCC 12228) and Streptococ-
cus pyogenes (S. pyogenes, ATCC 19615) and, gram-negative Pseudomonas aeruginosa (P. aeruginosa, ATCC 27853) and 
Klebsiella pneumoniae (K. pneumoniae, ATCC 13883) using the agar well diffusion assay and microtitre plate serial dilution 
method. The palladium complexes were active against the selected bacteria with the imidazole ring containing complex C2 
and indole heterocyclic ring containing complex C3 showing the highest activity.
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Introduction
The increased resistance of pathogenic bacteria to antibiotics 
is alarming, hence the need for new classes of antibacte-
rial agents (Theuretzbacher 2011). These new antibacterial 
agents should ideally be able to evade the bacterial resist-
ance mechanisms. The discovery and successful application 
of cis-diamminedichloroplatinum(II) complex as an antican-
cer agent triggered research interests in the development 
of transition metal-based therapeutic agents (Rosenberg 
et al. 1969). Platinum group metal complexes have gained 
immense popularity as possible antibacterial agents (Kapdi 
and Fairlamb 2014; Wilson and Lippard 2014; Zeng et al. 
2017). Research has shown that coordination of biologically 
active organic molecules to transition metals give a range of 
coordination geometries which provide more stereochemi-
cal orientations than what is possible with organic mole-
cules, thus aiding in their specific biomolecule recognition 
and interaction (Chohan et al. 1997; Nyawade et al. 2015; 
Selvakumar et al. 2006; You et al. 2008). For instance, a 
palladium complex of tetracycline was reported to be 15 
times more potent against Escherichia coli, which is resist-
ant to tetracycline, than the free tetracycline (Guerra et al. 
2005). The antimicrobial activities of palladium(II) and 
platinum(II) complexes have been shown against selected 
bacterial strains. Such complexes have also been shown to 
be more active than the free, uncoordinated ligands (Radic 
et al. 2012; Samota and Seth 2010).
Schiff bases have exhibited a wide range of biological 
activities which include antimicrobial (AlAjmi et al. 2016; 
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Karamunge and Vibhute 2013; Keypour et al. 2013; Tabas-
sum et al. 2013; Yao et al. 2007), anticancer (Kapdi and Fair-
lamb 2014; Sztanke et al. 2013; Tabassum et al. 2013; Yan 
et al. 2015)_ENREF_6, anti-inflammatory, (Asif and Husain 
2013; Coskun et al. 2013), antiretroviral (Sridhar et al. 
2001), anticonvulsive (Abu-Surrah and Kettunen 2006) and 
antipyretic activities (AlAjmi et al. 2016). The presence of a 
lone pair of electrons in the  sp2 orbital of the nitrogen atom 
in the azomethine group, –C = N–, of the Schiff bases is of 
chemical, biological and physical importance (Patai 1970). 
The biological activity of the Schiff bases is attributed to the 
formation of hydrogen bonds between the active centers of 
cell constituents and the  sp2 hybridized orbital of the azome-
thine nitrogen atom (Abdel-Rahman et al. 2017, 2019; Abu-
Dief and Mohamed 2015; Kabak et al. 1999). Schiff bases 
are generally easy to synthesize, derivatize and have good 
donor abilities. These compounds are, thus, suitable drug 
candidates. Amino acid Schiff bases are specifically very 
effective chelating ligands bearing carboxylate, COO– and 
azomethine –C = N– groups which readily coordinate to var-
ious transition metal ions, forming chemically and thermally 
stable metal complexes (Grünwald et al. 2010)_ENREF_9. 
The formation of palladium chelates through the use of 
amino acid Schiff bases is likely to enhance their stability 
and improve their structural lability. Chelation by the Schiff 
bases reduces the metal ion polarity and increase delocaliza-
tion of the π-electrons over the chelate ring (Ali et al. 2015) 
resulting in the formation of Schiff base transition metal 
chelates that exhibit useful physiological and pharmacologi-
cal activities. These activities are due to the enhanced lipo-
philicity of the central metal (Ali et al. 2015; Patai 1970). 
There is, therefore, great interest in the bioactivities of Schiff 
base transition metal complexes because their coordination 
to transition metal ions enable them to enter target cells and 
enhance their biological activities (Crans et al. 2013; Nagesh 
et al. 2015). Amino acid Schiff base metal chelates are a new 
category of potential antifungal, antiviral, antibacterial and 
antitumor agents (Abdel-Rahman et al. 2016, 2017, 2019; 
Abu-Dief and Mohamed 2015; Wei et al. 2011).
The amino acid, l-histidine, has an imidazole tail which 
accounts for many of its biochemical activities. Imidazole 
and its derivatives have occupied a unique place in the field 
of medicinal chemistry by improving pharmacokinetic prop-
erties of lead molecules. Imidazole derivatives have broad 
spectrum pharmacological properties and have exhibited 
good antimicrobial, anticancer, analgesic and anxiolytic 
properties (Adinolfi et al. 2015; Desai et al. 2014; Eicher 
1998; Khalid et al. 2005; Ramagiri et al. 2015; Kadavakollu 
et al. 2014, Verma 2013). The amino acid l-tryptophan has 
an indole nucleus, a generally accepted pharmacophore in 
medicinal compounds, which has shown some biological 
activities such as anti-inflammatory and analgesic, antifun-
gal, antibacterial, insecticidal, anticancer, HIV inhibitory, 
antioxidant, antitubercular, antiviral, antidepressant, tran-
quilizing and anticonvulsant, and antihistamine (Singh and 
Singh 2018). Compounds that contain imidazole and indole 
are of interest in medicinal chemistry due to their pharma-
cological and therapeutic activities.
Palladium (II) chelates are more effective anticancer 
agents than other metal chelates including platinum because 
they enable the metal to interact directly with the target 
deoxyribonucleic acid (DNA) molecule (Das and Living-
stone 1978). On the contrary, platinum (II) chelates are 
kinetically inert, while metals such as nickel (II), zinc (II), 
and copper (II) are thermodynamically unstable (Garoufis 
et al. 2009). Palladium (II) ions readily form complexes with 
amino acids, proteins, DNA and other macromolecules such 
as vitamin B6 (Rîmbu et al. 2014). The structural stability 
and lability of palladium complexes make palladium (II) the 
metal of choice in the search for therapeutic metals. Fur-
thermore, it has been shown that palladium compounds are 
not mutagenic and from this perspective is, therefore, safe 
for application in therapeutics (Melber 2002). However, the 
biological activity of palladium complexes of amino acid 
Schiff bases has not been greatly studied. Therefore, the aim 
of this study was to synthesize, characterize and assess the 
antibacterial activity of three new palladium (II) complexes 
of amino acid Schiff bases derived from pyrrole-2-carbox-
aldehyde and, l-methionine, l-histidine and l-tryptophan.
Experimental
All reactions were performed under inert conditions using 
Schlenk techniques. The amino acids and pyrrole-2-car-
boxaldehyde were purchased from Sigma Aldrich and used 
without further purification. Ethanol was obtained from 
Sigma Aldrich and dried by refluxing over magnesium turn-
ings and iodine before use. Diethyl ether was obtained from 
Sigma Aldrich and dried by refluxing over sodium wire and 
benzophenone. Melting points were determined using a Stu-
art Scientific SMP 10 apparatus and are uncorrected. Solid-
state Fourier Transform infrared (FT-IR) on potassium bro-
mide (KBr) were recorded on a Perkin Elmer Spectrum Two 
model FT-IR Spectrophotometer (4000–400 cm−1). 1H NMR 
of the compounds, in deuterated dimethylsulfoxide (DMSO-
d6) using TMS as an internal standard, was recorded at 25 °C 
on a Bruker Avance III HD Nanobay 400-MHz NMR spec-
trometer equipped with a 5-mm BBO probe. Electronic spec-
tra were recorded on a Thermo Scientific Nicolet Evolution 
100 Ultraviolet visible (UV–Vis) Spectrophotometer. Con-
ductivity measurements were performed on a HANNA EC 
215 Conductivity Meter. Elemental analyses were performed 
on a LECO CNHS-932 micro-analyzer. The metal precursor 
[Pd(COD)Cl2] was prepared following literature methods 
(Gao et al. 2014; Wiedermann et al. 2006). The amino acid 
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Schiff bases were synthesized by slight modification of the 
procedure reported in literature (Alsalme et al. 2016; Heinert 
and Martell 1962).
Synthesis of the Schiff bases potassium 
pyrrole‑2‑carbal amino acidate, L
An ethanolic solution of pyrrole-2-carboxaldehyde 
(1.0 mmol, 5.0 mL) was added to a solution of the amino 
acid (l-methionine (L1), l-histidine (L2) and l-tryptophan 
(L3) in  KOH(aq)) (1.0 mmol, 5.0 mL)/ethanol (5.0 mL) 
mixture. The resultant mixture was stirred under reflux 
for 6–8 h. The mixture was cooled and filtered to remove 
any unreacted amino acid. A yellow to orange filtrate was 
removed by vacuum suction and an orange to dark brown 
residual solid formed. The solid was re-crystallized using 
ethanol, washed with cold ethanol and rinsed with diethyl 
ether. The solid was dried under vacuum and characterized 
by FTIR, NMR, UV–Vis, and elemental analysis.
Potassium 2‑pyrral‑L‑methioninate, L1
Yield: 74%. Color: yellow. Molecular formula: 
 C10H13KN2O2S. Elemental analysis: Calculated: C; 45.45, 
H; 4.96, N; 10.60, S; 12.13%. Found: C; 45.66, H; 4.44, 
N; 10.94, S; 13.26%. 1H NMR (320 MHz, DMSO-d-6): 
δ 7.85 (s, N = C(H), imine), δ 6.06–6.88 (CH, Pyrrole), 
δ 3.52 (dd, α-CH, L-met), δ 2.37 (dd, δ -CH2, L-met), δ 
1.90, 2.05 (m, β-CH2, L-met), δ 2.01 (s, S-CH3, L-met). IR 
(KBr, solid state;  cm−1): ν(HC = N) 1597, ν(COO−)asym 
1418, ν(COO−)sym 1358, ν(S–C) 744. UV–Vis: λmax (nm) 
(DMSO): 288, 328, 433. Mpt: 269 °C.
Potassium 2‑pyrral‑L‑histidinate, L2
Yield: 23.3% yield. Color: orange. Molecular formula: 
 C11H11KN4O2. Elemental analysis: Calculated: C; 56.89, 
H; 5.21, N; 23.28%. Found: C; 56.06, H; 5.92, N; 22.84%. 
1H NMR (320  MHz, DMSO-d6): δ 7.82 (s, N = C(H), 
imine), δ 7.11–7.43 (N–C(H) = C, imidazole), δ 6.83–6.05 
(C(H), Pyrrole), δ 3.14 (dd, α-CH, L-hist), δ 3.67, 2.92 (m, 
β-CH2, L-hist). IR (KBr, solid state;  cm−1): ν(HC = N) 1622, 
ν(COO−)asym 1412, ν(COO−)sym 1345. UV–Vis: λmax (nm) 
(DMSO): 288, 325, 436. Mpt: 255 °C.
Synthesis of potassium 2‑pyrral‑L‑tryptophanate, L3
Yield: 41% yield. Color: orange. Molecular formula: 
 C16H14KN3O2. Elemental analysis: Calculated: C; 60.17, H; 
4.42, N; 13.16%. Found: C; 59.08, H; 4.83, N; 13.66%. 1H 
NMR (320 MHz, DMSO-d6): δ 7.78 (s, N = C(H), imine), δ 
7.55–6.85 (benzyl C(4H), indole), δ 6.91–6.29, 6.02 (CH, 
Pyrrole), δ 3.83(dd, α-CH, L-trypt), δ 3.39, 3.30 (m, β-CH2, 
L-hist), δ 7.00 (N = C(H)–N, Indole). IR (KBr, solid state; 
 cm−1): ν(HC = N) 1622, ν(COO−)asym 1398, ν(COO−)sym 
1354. UV–Vis: λmax (nm) (DMSO): 220, (282, 289), 329, 
436. Mpt: 113 °C.
Synthesis of the 2‑pyrral‑L‑amino acid palladium(II) 
complexes C1, C2 and C3,  [PdLCl]2H2O
A solution of dichloro(1,5-cyclooctadiene)palladium(II) 
(157.0 mg; 0.55 mmol) in 5.0-mL dry dichloromethane was 
added dropwise to an equimolar ethanolic solution of the 
Schiff base (L1, L2 and L3) (5 mL) in a clean dry Schlenk 
tube. The mixture was stirred at 25 °C temperature for 6 h. A 
dark orange precipitate was formed. The mixture was filtered 
and the residue was washed with cold methanol and rinsed 
with diethyl ether. The solid was dried under reduced pres-
sure and characterized using FTIR, 1H NMR, UV–Vis and 
elemental analysis.
2‑pyrral‑l‑methionine palladium(II) complex, C1 
 [PdL1Cl]2H2O
Molecular formula:  C10H17ClN2O4PdS. Elemental analysis: 
Calculated: C; 29.79, H; 4.24, N; 6.95, S; 7.95%. Found: 
C; 29.49, H; 3.9, N; 6.33, S; 7.51%. 1H NMR (320 MHz, 
MeOD): δ 8.32 (s, N = C(H), imine), δ 7.21-6.06 (C(H), Pyr-
role), δ 4.02 (dd, α-CH, L-met), δ 3.39 (H,  H2O), δ 3.25 (dd, 
δ-CH2, L-met), δ 2.63, 2.06 (m, β-CH2, L-met), δ 2.06 (s, 
S-CH3, L-met). IR (KBr, solid state;  cm−1): ν(OH–O) 3450, 
ν(OC = O) 1726.1, ν(HC = N) 1578, ν(COO−)asym 1418, 
ν(COO−)sym 1316, ν(S = C) 1210, ν(S–C) 751, ν(M–O) 
588, ν(M–N) 433. UV–Vis: λmax (nm) (DMSO): 302, 338, 
374, 444, 522. Mpt: 150 °C.
2‑pyrral‑l‑histidine palladium(II) complex, C2  [PdL2Cl]2H2O
Molecular formula:  C11H15ClN4O2Pd. Elemental analysis: 
Calculated: C; 32.29, H; 3.70, N; 13.69%. Found: C; 33.01, 
H; 3.62, N; 13.11%. 1H NMR (320 MHz, DMSO-d6): δ 
12.76 (N(H), imidazole), δ 9.47 (C = C(H)–N, imidazole), 
8.13 (N = C(H), imine), 7.12(s, N–C(H) = C, imidazole), δ 
7.2, 7.0, 6.28 (CH, Pyrrole), δ 4.40 (dd, α-CH, L-hist), δ 
5.0, 2.93 (m, β-CH2, L-hist), δ 3.37 (H,  H2O). IR (KBr, solid 
state;  cm−1): ν(OH–O) 3424, ν(OC = O) 1723.8, ν(HC = N) 
1608, ν(COO−)asym, 1418, ν(COO−)sym 1309, ν(M–O) 
622, ν(M–N) 447. UV–Vis: λmax (nm) (DMSO): 303, 378, 
459, 518. Mpt > 250 °C.
2‑pyrral‑l‑tryptophan palladium(II) complex, C3 
 [PdLCl]2H2O
Molecular formula:  C16H18ClN3O2Pd. Elemental analysis: 
Calculated: C; 49.91, H; 3.96, N; 19.94%. Found: C; 50.01, 
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H; 3.55, N; 20.32%. 1H NMR (320 MHz, DMSO-d6): δ 9.33 
(NH, Pyrrole), δ 11.05 (s, N(H), indole), δ 8.21 (s, N = C(H), 
imine), δ 7.23 (N–C(H) = C, indole), δ 7.58–7.00 (CH, Pyr-
role), δ 4.14 (dd, α-CH, L-trypt), δ 3.37 (O(H),  H2O), δ 2.29 
(m, β-CH2, L-hist), δ 7.58–77.00 (CH, indole). IR (KBr, 
solid state;  cm−1): ν(OH–O) 3453, ν(OC = O) 1735.43, 
ν(HC = N) 1608, ν(COO−)asym, 1411, ν(COO−)sym 1342, 
ν(M–O) 598, ν(M–N) 430. UV–Vis: λmax (nm) (DMSO): 
290, 335, 382, 482, 522. Mpt: 170 °C.
Evaluation of antibacterial activity
The antibacterial activity of the amino acid Schiff bases 
and their metal complexes were tested against Staphylo-
coccus epidermidis (SE), Pseudomonas aeruginosa (PA), 
Streptococcus pyogenes (SP), Klebsiella pneumoniae (KP), 
Methicillin-resistant Staphylococcus aureus (MRSA) and 
Staphylococcus aureus (SA) using the agar well diffusion 
assay (Rahman et al. 2015). The lowest concentration of 
the samples that inhibits the visual growth of the bacteria, 
i.e., the minimum inhibitory concentration (MIC) was also 
determined in micro-dilution (Balouiri et al. 2016). Micro-
bial suspensions in Mueller–Hinton broth were incubated for 
24 h at 37 °C, from which a McFarland No. 0.5 standard at 
a spectrophotometric wavelength of 625 nm was prepared.
Agar well diffusion assays
Solutions of the synthesized ligands L1, L2 and L3, and their 
respective palladium complexes C1, C2 and C3 (10 mg/mL) 
were prepared by dissolving in 10% DMSO. Mueller–Hinton 
agar was inoculated with the respective test microorganisms 
(inoculum size: 1 × 108 CFU/ml of bacteria) (Balouiri et al. 
2006). Holes (6 mm in diameter) were punched into the agar 
plates using a sterile cork borer and 50 μl of the respective 
sample solution were introduced into each well. The broad 
spectrum antibiotic ampicillin was used as the positive con-
trol while 10% DMSO was used as the negative control. The 
plates were then incubated at 37 °C for 24 h. The inhibition 
zones were measured in millimeters (mm) from the circum-
ference of the well to that of the growth-free zones around 
the disk (Table 1). All samples were tested in triplicate (Rah-
man et al. 2015). 
Minimum inhibitory concentration (MIC)
The MIC for each sample was determined using the micro-
titer plate method (Balouiri et al. 2016). Mueller–Hinton 
broth was inoculated with single colonies of bacterial strains 
and incubated for 24 h at 37 °C. A McFarland No. 0.5 bacte-
rial suspension was prepared and further diluted as described 
by Balouiri, et al. (Balouiri et al. 2016). Ampicillin, a broad 
spectrum antibiotic, was used as a positive control (to con-
firm microbial susceptibility). DMSO (10%) served as the 
negative control. In a laminar flow cabinet, 96-well micro-
titer plates were aseptically prepared as follow. The ligand 
and complexes were dissolved in 10% DMSO (DMSO was 
diluted using the respective broth) to starting concentrations 
of 2.5 mg/ml. In each well of the microtiter plate, 100 µl of 
broth was added except for the first wells in which 200 µl of 
the ligand/broth or complex/broth solution was added. Two-
fold serial dilutions were made across the plate, such that 
the full range of concentrations tested was 0.0049–2.5 mg/
ml. The respective bacterial suspensions were added to the 
wells except to one well, which was used as the background 
interference standard. The plates were incubated for 24 h at 
37 °C. After incubation, the absorbance reading at 625 nm, 
for each plate, was recorded on a POLARstar Omega spec-
trophotometer (BMG labtech, Germany). The MIC deter-
mined by the spectrophotometric method was defined as 
the concentration at which there was a sharp decline in the 
absorbance value after incubation (Devienne and Raddi 
2002). Growth inhibition was confirmed by visual inspec-
tion of the wells.
Results and discussion
Synthesis and characterization of the Schiff base
The Schiff base ligands L1, L2 and L3 were synthesized by 
condensation of pyrrole-2-carboxaldehyde with the amino 
Table 1  Infrared and proton NMR data for the ligands and complexes
Compound FTIR  cm−1 1H NMR ppm
ν(H2O) ν(OC = O) ν(HC = N) ν(COO−) asym ν(COO−) sym ν(M–O) ν(M–N) δ(H–C = N) δ(H–OH)
L1 – 1597 1418 1358 – – 7.85
C1 2450 1726 1578 1418 1316 588 455 8.32 3.39
L2 – 1622 1412 1345 7.88
C2 3424 1724 1608 1418 1309 622 477 8.13 3.37
L3 – 1633 1398 1356 7.78
C3 3453 1735 1625 1411 1342 598 430 8.21 3.37
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acids l-methionine, l-histidine and l-tryptophan, respec-
tively, in the ration of 1:1 (Scheme 1).
The Schiff bases, pale yellow-to-orange solids, are air and 
moisture sensitive, soluble in water, methanol, ethanol and 
DMSO, but insoluble in non-polar solvents. The infrared 
and NMR data of the ligands and complexes are provided 
in Table 1.
Strong vibration frequencies assignable to the ν(HC = N) 
were observed at 1597 cm−1, 1622 cm−1 and 1633 cm−1 for 
ligands L1, L2 and L3, respectively. The ν(HC = N) vibra-
tions are at a lower frequency than that observed for the 
carbonyl group of pyrrole-2-carboxaldehyde, ν(HC = O) 
at 1639 cm−1, a clear indication that the azomethine group 
replaced the carbonyl group during the Schiff base ligand 
formation (Abu-Dief and Mohamed 2015, Arish and 
Nair 2012). The asymmetric carboxylate stretching bands 
νasym(COO––) were observed in the range 1418–1398 cm−1 
while the symmetric stretching band νsym(COO––) was 
observed in the range 1347–1361 cm−1 (Rîmbu et al. 2014). 
The ν(C–S) band was observed at 744 cm−1 for ligand L1.
Formation of the Schiff base was further confirmed by 
the presence of a strong singlet peak at 7.75–7.85 ppm, in 
1H NMR spectrum, assignable to the azomethine proton, 
H–C = N. The absence of the carbonyl proton H–C = O sig-
nal (9.80 ppm) from the spectrum of the Schiff bases fur-
ther confirmed the formation of the Schiff base. The pyrrole 
proton signals were observed in the range 6.08–6.88 ppm. 
The elemental analysis data (Table 2) are consistent with 
the calculated values, a further proof that the Schiff base 
was synthesized.
The UV–Vis absorption bands (Table 3) for the ligands 
were observed at; 282–290 nm assignable to π–π* transitions 
in the pyrrole rings, ~ 325–329 nm assignable to π–π* transi-
tions in the azomethine bond and ~ 433–436 nm assignable 
to n–π* transition for the azomethine.
Synthesis and characterization of the metal 
complexes
The metal complexes (Fig. 1) were synthesized by the reac-
tion of the pyrral-2-amino acid Schiff bases with [Pd(COD)
Cl2] in the ratio of 1:1 at room temperature (Scheme 2).
The metal complexes were obtained as orange to dark 
brown solids soluble in DMSO, DMF, ethanol and methanol 
Scheme 1  Synthesis of 
L-amino acid Schiff base 
ligands L1, L2 and L3




Elemental analysis UV–Vis (λmax, nm) Melting 
point 
°CC H N S
L1  C10H13KN2O2S 264.38 45.66 (45.45) 4.44 (4.96) 10.94 (10.60) 13.26 (12.13) 205, 288, 328, 433, 269
C1  C10H17ClN2O4PdS 403.19 29.79 (29.49) 4.25 (3.90) 6.95 (6.33) 7.95 (7.51) 302, 338, 374, 444, 522 150
L2  (C11H11KN4O2) 270.33 56.06 (56.89) 5.92 (5.21) 22.84 (23.28) 205, 288, 325, 436 255
C2  C11H15ClN4O4Pd 409.14 32.29 (33.01) 3.70 (3.62) 13.69 (13.11) 303, 378, 459, 518 –
L3  (C16H14KN3O2) 319.41 59.08 (60.17) 4.83 (4.42) 13.66 (13.16) 203, 220, (282, 289), 329, 436 113
C3  C16H18ClN3O4Pd 458.21 49.91 (50.01) 3.96 (3.55) 19.94 (20.32) 290, 335, 382, 482, 522 170
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but insoluble in non-polar solvents such as chloroform and 
methylene chloride. The metal complexes were character-
ized by FTIR, UV–Vis, 1HNMR and elemental analysis 
(Tables 2 and 3). The IR spectrum of the complexes showed 
strong bands in the range 1578–1625 cm−1 associated with 
the ν(C = N) stretch. The ν(C = N) stretching frequencies 
appeared lower than that observed for the free Schiff base 
ligands by approximate 22 cm−1. This is most likely a result 
of coordination to the metal via the electron rich azome-
thine nitrogen (Abdel-Rahman et al. 2019; Abu-Dief and 
Mohamed 2015). The electron density on the azomethine 
bond decreases; hence, π character decreases, the bond order 
decreases and the C = N bond strength decreases. The car-
boxylate group symmetric stretch, ν(OC–O−)sym, shifted 
to lower frequency compared to the free ligand, a sign of 
coordination to the metal center via the carboxylate ion. This 
is a probable sign that there is less resonance upon coordina-
tion of the Schiff base to the metal center via the negatively 
charged end of the carboxylate ion. It is worth noting that 
new bands associated with carboxylic acid ν(−OC = O)asym 
stretch, absent in the ligand IR spectrum, were observed at 
1735–1724 cm−1. This observation also suggests decrease 
in resonance as a result of coordination via the electron 
rich negatively charged oxygen  (O−) of the carboxylate 
ion. The large difference of about 200 cm−1 between the 
ν(OC–O−)sym and ν(OC = O)asym vibrations is an indicator 
of the monodentate binding nature of the carboxylate group 
in the complexes (Arish and Nair 2012; Deacon and Phil-
lips 1980; Nakamoto et al. 1961). New bands assignable to 
ν(M–O) and ν(M–N) stretching vibrations were observed at 
588 cm−1 and 433 cm−1, respectively (Arish and Nair 2012; 
Nakamoto et al. 1961; Ouf et al. 2010). The metal–oxygen 
and metal–nitrogen bond stretching vibrations are conclusive 
evidence of coordination via oxygen of the carboxylate and 
nitrogen of the azomethine groups. The infrared analysis 
suggests that the Schiff bases are coordinated to the metal 
ion via nitrogen and oxygen atoms. The presence of a strong, 
broad peak in the IR spectra of the complexes in the region 
3400–3500 cm−1 is assignable to water molecules associated 
with the complexes.
The proton NMR data further confirmed the coor-
dination mode of the Schiff bases to the metal center. 
The azomethine proton NMR peak shifted downfield 
to 8.1–8.32  ppm compared to the free ligand peak at 
7.78–7.98 ppm. The azomethine proton is more deshielded 
in the metal complex as the π character of the C = N bond 
Fig. 1  Structure of the complexes C1, C2 and C3
Scheme 2  Synthesis of the palladium(II) L-amino acid Schiff base complexes
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increases on coordination to the metal center. The α-CH 
protons signal in the metal complex shifted downfield as 
electrons are pushed towards the nitrogen atom for coordi-
nation. No signal was observed for the pyrrole NH proton 
in both the ligands and their corresponding complexes. 
A slight up-field shift of about 0.5 ppm was observed on 
the pyrrole CH protons of the complexes with respect to 
the free ligand. This observation suggests coordination of 
the ligand to the metal via the nitrogen atom of the pyr-
role ring. It is worth noting that a broad sharp peak was 
observed at 3.2 ppm in all the complexes, a sign that water 
is probably associated with the palladium complexes.
The UV–Vis absorption bands in the complexes for the 
azomethine C = N bonds observed at ~ 338 nm were assigned 
to the π–π* transitions and 378–389 nm assigned to the n–π* 
transitions, a Bathochromic shift with respect to absorptions 
observed for the free ligands (Ali et al. 2006; Biyala et al. 
2008). This is an indication that coordination of the ligands 
to the metal center occurred via the azomethine nitrogen 
atom. The UV absorption band associated with the pyrrole 
n–π* transitions is observed at 303 nm, a bathochromic shift 
with respect to the absorptions observed in the ligand. This 
suggests that the ligand is probably coordinated to the metal 
via the pyrrole nitrogen. Ligand to metal charge transfer can 
be assigned the strong bands observed at 444–459 nm in the 
metal complexes (Biyala et al. 2008). The LMCT supports 
bonding via the oxygen atom of the carboxylate group. New 
absorption bands were appeared in the regions 378–382 nm 
and 518–522 nm. Palladium (II) with  4d8 electronic con-
figuration is expected to exhibit a square planar geom-
etry associated with the three d–d transitions; 1A1g → 1A2g 
(463–522 nm), 1A1g → 1B1g (405–418 nm) and 1A1g → 1Eg 
(344–386 nm) (Lever 1984). It is worth noting that the 
electronic spectra of palladium(II) complexes, in which a 
chalcogen is coordinated to the metal, are complicated since 
tails of strong O → M LMCT band extends into the visible 
section of the spectrum thereby masking the expected d–d 
transition bands (Ali et al. 2006). However, in this study, 
bands observed in the regions 518–522 nm, 444–459 nm 
and 374–382 nm of the electronic spectra of the complexes 
can be assigned to 1A1g → 1A2g, 1A1g → 1B1g and 1A1g → 1Eg, 
respectively (Biyala et al. 2008).
Conductivity measurements of solutions the metal com-
plexes in DMSO were the same as that observed for pure 
DMSO (Table 3). This is an indication that the complexes 
are neutral non-electrolytes with coordinated chloride.
The palladium(II) complexes can, therefore, be assigned a 
square planar geometry based on the UV–Vis, IR and NMR 
spectra. Each ligand is coordinated to the palladium(II) ion 
in a tridentate manner with a chloride ion occupying the 
fourth position and two water molecules associated with 
the complexes as water of hydration outside the coordina-











































































































































































































































































































is coordinated to the metal center via the azomethine nitro-
gen, the pyrrole nitrogen and  O– of the carboxylate group.
Antibacterial activity
Preliminary antibacterial activity of the ligands L1, L2 and 
L3, and their respective palladium (II) complexes C1, C2 
and C3 was performed against Staphylococcus epidermidis 
(SE), Pseudomonas aeruginosa (PA), Streptococcus pyo-
genes (SP), Klebsiella pneuminiae (KP), Methicilin Resist-
ant Staphylococcus aureus (MRSA) and Staphylococcus 
aureus (SA) using the agar well diffusion assay. The diam-
eters of the zones of inhibitions are tabulated in Table 4.
Zones of inhibition were observed for C3 for all the bac-
terial strains used in this study, except for P. aeruginosa. 
Zones of inhibition were observed for C1 and C2 against all 
the bacterial strains except for P. aeruginosa and K. pneu-
monia. P. aeruginosa was, thus, resistant to all the tested 
compounds including ampicillin. The antimicrobial activi-
ties of C1 and C2 were statistically similar; whilst C1 and 
C3, and C2 and C3, respectively, were significantly different 
against all the tested bacteria except against P. aeruginosa. 
No zones of inhibition were observed for wells containing 
the ligands, which suggest that the ligands did not inhibit the 
growth of any of the tested bacterial strains. Arish and Nair 
(2012) previously found that pyrral-L-histidinate, a ligand 
identical to L2, demonstrated antibacterial activity against 
P. aeruginosa and S. aureus.
The MIC values were determined for the ligands (L1, L2 
and L3) and metal complexes (C1, C2 and C3) against six 
bacterial strains (Table 5). The lowest MIC (0.078 mg/mL) 
was observed for C3 against S. epidermidis, S. aureus and 
MRSA. The same MIC value was obtained for C2 against 
S. epidermidis. MIC values for all the other treatments 
were higher than 0.078 mg/mL. The highest MIC value 
(0.625 mg/mL) was obtained for C1 against S. pyogenes, 
S. aureus and MRSA. The micro-dilution assay confirms 
that the P. aeruginosa is resistant to C1, C2 and C3, as the 
MIC values could not be established against this organism. 
Although it was shown using the disk diffusion assay that C3 
was able to produce a zone of inhibition for K. pneumonia, 
an MIC value for C3 could not be determined against this 
organism. The micro-dilution assay again confirmed that K. 
pneumonia was resistant to C1 and C2. The MIC values for 
the ligands were more than 2.5 mg/ml and confirm that the 
ligands do not have an antibacterial activity at the concentra-
tions tested in this study.
The differences in activities of the tested complexes can 
be attributed to the different amino acid tails, present in the 
ligands. For instance, the imidazole and indole tails, which 
are known pharmacophores, enhanced the antibacterial 
activity of the complexes. Imidazole is a polar and ionisable 
aromatic compound that improves pharmacokinetic prop-
erties of lead molecules. The imidazole ring, for instance, 
is present in many antimicrobial drugs such as antifungals, 
nitroimidazole series of antibiotics and the sedative imida-
zolam. The indole nucleus, a biologically accepted phar-
macophore in medicinal compounds, has shown biological 
activities such as anti-inflammatory and analgesic, antifun-
gal, antimicrobial, insecticidal, anticancer, HIV inhibitor, 
antioxidant, antituberculosis, antiviral, antidepressant, tran-
quilizing and anticonvulsant, and antihistamine (Singh and 
Singh 2018). This explains why both complexs C2 and C3 
which bear the imidazole and indole tails, respectively, are 
more active against the bacteria strains used in this study 
than complex C1 which bears an aliphatic sulfur group.
Conclusions
The ligands L1, L2 and L3, and their respective palladium 
(II) complexes C1, C2 and C3 were successfully synthe-
sized. The ligands are tridentate and are coordinated to the 
metal center via the pyrrole nitrogen, imine nitrogen and 
the amino acid anionic oxygen. The complexes showed 
good antimicrobial activity against the tested bacteria with 
complexes C3 and C2 exhibiting stronger antibacterial 
activity than complex C1. The amino acid tail used has a 
direct influence on the activity of the 2-pyrral amino acid 
palladium(II) complexes. The aliphatic sulfur group (com-
plex C1) had minimal influence while the imidazole and 
indole rings exhibited the best antibacterial activity at the 
Table 5  Minimum inhibitory 
concentrations (MIC) results for 
the complexes
Compounds Bacterial species
S. epidermidis P. aeruginosa S. pyogenes K. pneumoniae MRSA S. aureus
C1 0.315 – 0.625 – 0.625 0.625
C2 0.078 – 0.156 – 0.156 0.156
C3 0.078 – 0.156 – 0.078 0.078
CODPdCl2 0.315 – 0.625 0.625 0.625 0.625
Ampicillin 0.04 0.02 0.02 0.63 0.31 0.02
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lowest concentrations of complexes C2 and C3. The ligands 
did not show any antibacterial activities against any of the 
bacterial species tested despite literature reports that amino 
acid Schiff bases are active against various bacterial species 
(Arish and Nair 2012). The reason for this deviation is not 
known.
Acknowledgements We would like to thank Jomo Kenyatta Univer-
sity of Agriculture and Technology in Kenya for granting Dr. Eunice 
Nyawade study leave to undertake this study at the University of the 
Western Cape, South Africa. We would also like to thank the UWC for 
allowing us to use their chemistry laboratory to do the synthesis and 
characterization work, and DST/Mintek Nanotechnology Innovation 
Centre for perfoming the antibacterial studies.
Funding This work was supported by the National Research Founda-
tion, South Africa.
References
Abdel-Rahman LH, Abu-Dief AM, Ismael M, Mohamed MAA, 
Hashem NA (2016) Synthesis, structure elucidation, biologi-
cal screening, molecular modeling and DNA binding of some 
Cu(II) chelates incorporating imines derived from amino acids. 
J Mol Struct 1103:232–244. https ://doi.org/10.1016/j.molst 
ruc.2015.09.039
Abdel-Rahman LH, Abu-Dief AM, Aboelez MO, Hassan Abdel-
Mawgoud AA (2017) DNA interaction, antimicrobial, antican-
cer activities and molecular docking study of some new VO(II), 
Cr(III), Mn(II) and Ni(II) mononuclear chelates encompass-
ing quaridentate imine ligand. J Photochem Photobiol B Biol 
170:271–285. https ://doi.org/10.1016/j.jphot obiol .2017.04.003
Abdel-Rahman LH, Abu-Dief AM, Shehata MR, Atlam FM, Abdel-
Mawgoud AAH (2019) Some new Ag(I), VO(II) and Pd(II) che-
lates incorporating tridentate imine ligand: design, synthesis, 
structure elucidation, density functional theory calculations for 
DNA interaction, antimicrobial and anticancer activities and 
molecular docking studies. Appl Organomet Chem 33:e4699. 
https ://doi.org/10.1002/aoc.4699
Abu-Dief AM, Mohamed IMA (2015) A review on versatile applica-
tions of transition metal complexes incorporating Schiff bases. 
Beni-Suef University. J Basic Appl Sci 4:119–133. https ://doi.
org/10.1016/j.bjbas .2015.05.004
Abu-Surrah AS, Kettunen M (2006) Platinum group antitumor chem-
istry: design and development of new anticancer drugs comple-
mentary to cisplatin. Curr Med Chem 13:1337–1357. https ://
doi.org/10.2174/09298 67067 76872 970
Adinolfi B, Carpi S, Romanini A, Da Pozzo E, Castagna M, Costa B 
et al (2015) Analysis of the antitumor activity of clotrimazole 
on A375 human melanoma cells. Anticancer Res 35:3781–3786
AlAjmi MF, Hussain A, Alsalme A, Khan RA (2016) In  vivo 
assessment of newly synthesized achiral copper(ii) and zinc(ii) 
complexes of a benzimidazole derived scaffold as a poten-
tial analgesic, antipyretic and anti-inflammatory. RSC Adv 
6:19475–19481. https ://doi.org/10.1039/C5RA2 5071D 
Ali MA, Mirza AH, Butcher RJ, Crouse KA (2006) The preparation, 
characterization and biological activity of Palladium(II) and 
Platinum(II) complexes of tridentate nns ligands derived from 
S-methyl- and S-benzyldithiocarbazates and the X-ray crystal 
structure of the [Pd(mpasme)Cl] complex. Trans Metal Chem 
31:79–87. https ://doi.org/10.1007/s1124 3-005-6305-3
Ali OAM, El-Medani SM, Abu Serea MR, Sayed ASS (2015) 
Unsymmetrical Schiff base (ON) ligand on complexation with 
some transition metal ions: synthesis, spectral characteriza-
tion, antibacterial, fluorescence and thermal studies. Spectro-
chim Acta A Mol Biomol Spectrosc 136:651–660. https ://doi.
org/10.1016/j.saa.2014.09.079
Alsalme A, Laeeq S, Dwivedi S, Khan MS, Al Farhan K, Musarrat J 
et al (2016) Synthesis, characterization of α-amino acid Schiff 
base derived Ru/Pt complexes: induces cytotoxicity in HepG2 
cell via protein binding and ROS generation. Spectrochim Acta 
A Mol Biomol Spectrosc 163:1–7. https ://doi.org/10.1016/j.
saa.2016.03.012
Arish D, Nair MS (2012) Synthesis, characterization and biologi-
cal studies of Co(II), Ni(II), Cu(II) and Zn(II) complexes with 
pyrral-l-histidinate. Arab J Chem 5:179–186. https ://doi.
org/10.1016/j.arabj c.2010.08.011
Asif M, Husain A (2013) Analgesic, anti-inflammatory, and antiplate-
let profile of hydrazones containing synthetic molecules. J Appl 
Chem 2013:7. https ://doi.org/10.1155/2013/24720 3
Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evalu-
ating antimicrobial activity: a review. J Pharmaceut Anal 6:71–79. 
https ://doi.org/10.1016/j.jpha.2015.11.005
Biyala MK, Sharma K, Swami M, Fahmi N, Singh RV (2008) Spectral 
and biocidal studies of palladium(II) and platinum(II) complexes 
with monobasic bidentate Schiff bases. Transit Met Chem 33:377–
381. https ://doi.org/10.1007/s1124 3-008-9053-3
Chohan ZH, Praveen M, Ghaffar A (1997) Structural and biological 
behaviour of Co(II), Cu(II) and Ni(II) metal complexes of some 
amino acid derived Schiff-bases. Met-Based Drugs 4:267–272. 
https ://doi.org/10.1155/mbd.1997.267
Coskun MD, Ari F, Oral AY, Sarimahmut M, Kutlu HM, Yilmaz VT 
et al (2013) Promising anti-growth effects of palladium(II) sac-
charinate complex of terpyridine by inducing apoptosis on trans-
formed fibroblasts in vitro. Bioorg Med Chem 21:4698–4705. 
https ://doi.org/10.1016/j.bmc.2013.05.023
Crans DC, Woll KA, Prusinskas K, Johnson MD, Norkus E (2013) 
Metal speciation in health and medicine represented by iron and 
vanadium. Inorg Chem 52:12262–12275. https ://doi.org/10.1021/
ic400 7873
Das M, Livingstone SE (1978) Cytotoxic action of some transition 
metal chelates of Schiff bases derived from S-methyldithiocarbaz-
ate. Br J Cancer 37:466–469. https ://doi.org/10.1038/bjc.1978.68
Deacon GB, Phillips RJ (1980) Relationships between the carbon-
oxygen stretching frequencies of carboxylato complexes and the 
type of carboxylate coordination. Coord Chem Rev 33:227–250. 
https ://doi.org/10.1016/S0010 -8545(00)80455 -5
Desai NC, Maheta AS, Rajpara KM, Joshi VV, Vaghani HV, Satodiya 
HM (2014) Green synthesis of novel quinoline based imidazole 
derivatives and evaluation of their antimicrobial activity. J Saudi 
Chem Soc 18:963–971. https ://doi.org/10.1016/j.jscs.2011.11.021
Devienne KF, Raddi MSG (2002) Screening for antimicrobial activity 
of natural products using a microplate photometer. Braz J Micro-
biol 33:166–168
Eicher T, Pozharskii AF, Soldatenkov AT, Katritzky AR (1998) Het-
erocycles in life and society, 1st edn. Wiley, New York, p 301
Gao E-J, Hong F, Zhu M-C, Ma C, Liang S-K, Zhang J et al (2014) 
Effect of carbon chain length on biological activity of novel pal-
ladium (II) complexes. Eur J Med Chem 82:172–180. https ://doi.
org/10.1016/j.ejmec h.2014.05.021
Garoufis A, Hadjikakou SK, Hadjiliadis N (2009) Palladium coordi-
nation compounds as anti-viral, anti-fungal, anti-microbial and 




Grünwald KR, Saischek G, Volpe M, Belaj F, Mösch-Zanetti NC 
(2010) Pyridazine-based ligands and their coordinating ability 
towards first-row transition metals. Eur J Inorg Chem 2010:2297–
2305. https ://doi.org/10.1002/ejic.20100 0120
Guerra W, de Andrade Azevedo E, de Souza Monteiro AR, Bucciar-
elli-Rodriguez M, Chartone-Souza E, Nascimento AMA et al 
(2005) Synthesis, characterization, and antibacterial activity of 
three palladium(II) complexes of tetracyclines. J Inorg Biochem 
99:2348–2354. https ://doi.org/10.1016/j.jinor gbio.2005.09.001
Heinert D, Martell AE (1962) Pyridoxine and pyridoxal analogs. V. 
syntheses and infrared spectra of Schiff bases. J Am Chem Soc 
84:3257–3263. https ://doi.org/10.1021/ja008 76a00 9
Kabak M, Elmali A, Elerman Y (1999) Keto–enol tautomerism, 
conformations and structure of N-(2-hydroxy-5-methylphenyl), 
2-hydroxybenzaldehydeimine. J Mol Struct 477:151–158. https 
://doi.org/10.1016/S0022 -2860(98)00604 -8
Kadavakollu S, Stailey C, Kunapareddy CS, White W (2014) Clotri-
mazole as a cancer drug: a short review. Med Chem 4:722–724. 
https ://doi.org/10.4172/2161-0444.10002 19
Kapdi AR, Fairlamb IJS (2014) Anti-cancer palladium complexes: a 
focus on PdX2L2, palladacycles and related complexes. Chem 
Soc Rev 43:4751–4777. https ://doi.org/10.1039/C4CS0 0063C 
Karamunge KG, Vibhute YB (2013) Synthesis and antimicrobial 
activity of some new Schiff bases. J Phys Conf Ser 423:012006
Keypour H, Shayesteh M, Rezaeivala M, Chalabian F, Elerman Y, 
Buyukgungor O (2013) Synthesis, spectral characterization, 
structural investigation and antimicrobial studies of mononu-
clear Cu(II), Ni(II), Co(II), Zn(II) and Cd(II) complexes of a 
new potentially hexadentate  N2O4 Schiff base ligand derived 
from salicylaldehyde. J Mol Struct 1032:62–68. https ://doi.
org/10.1016/j.molst ruc.2012.07.056
Khalid MH, Tokunaga Y, Caputy AJ, Walters E (2005) Inhibition of 
tumor growth and prolonged survival of rats with intracranial 
gliomas following administration of clotrimazole. J Neurosurg 
103:79–86. https ://doi.org/10.3171/jns.2005.103.1.0079
Lever ABP (1984) Inorganic electronic spectroscopy. Elsevier, 
Amsterdam
Melber CK, Keller D, Mangelsdorf I (2002) Environmental Health 
Criteria 226: Palladium. World Health Organization
Nagesh GY, Mahendra Raj K, Mruthyunjayaswamy BHM (2015) 
Synthesis, characterization, thermal study and biological evalu-
ation of Cu(II), Co(II), Ni(II) and Zn(II) complexes of Schiff 
base ligand containing thiazole moiety. J Mol Struct 1079:423–
432. https ://doi.org/10.1016/j.molst ruc.2014.09.013
Nakamoto K, Morimoto Y, Martell AE (1961) Infrared spectra 
of metal chelate compounds. IV. Infrared spectra of addition 
compounds of metallic acetylacetonates1a. J Am Chem Soc 
83:4533–4536. https ://doi.org/10.1021/ja014 83a01 0
Nyawade EA, Friedrich HB, Omondi B, Chenia HY, Singh M, 
Gorle S (2015) Synthesis and characterization of new α, 
α’-diaminoalkane-bridged dicarbonyl(η5-cyclopentadienyl)
ruthenium(II) complex salts: antibacterial activity tests of 
η5-cyclopentadienyl dicarbonyl ruthenium(II) amine complexes. 
J Organomet Chem 799–800:138–146. https ://doi.org/10.1016/j.
jorga nchem .2015.09.007
Ouf AE-F, Ali MS, Saad EM, Mostafa SI (2010) pH-metric and spec-
troscopic properties of new 4-hydroxysalicylidene-2-aminopy-
rimidine Schiff-base transition metal complexes. J Mol Struct 
973:69–75. https ://doi.org/10.1016/j.molst ruc.2010.03.037
Patai S (1970) Analysis of azomethines. Carbon–Nitrogen double 
bonds. Interscience, New york
Radić GP, Glođović VV, Radojević ID, Stefanović OD, Čomić 
LR, Ratković ZR et  al (2012) Synthesis, characteriza-
tion and antimicrobial activity of palladium(II) complexes 
with some alkyl derivates of thiosalicylic acids: crystal 
structure of the bis(S-benzyl-thiosalicylate)–palladium(II) 
complex, [Pd(S-bz-thiosal)2]. Polyhedron 31:69–76. https ://
doi.org/10.1016/j.poly.2011.08.042
Rahman LHA, Abu-Dief AM, Hashem NA, Seleem AA (2015) 
Recent advances in synthesis, characterization and biological 
activity of nano sized Schiff base amino acid M(II) complexes. 
Int J Nanomat Chem 1:79–95
Ramagiri RK, Thupurani MK, Vedula RR (2015) Synthesis, charac-
terization, and antibacterial activity of some novel substituted 
imidazole derivatives via one-pot three-component. J Hetero-
cycl Chem 52:1713–1717. https ://doi.org/10.1002/jhet.2261
Rîmbu C, Danac R, Pui A (2014) Antibacterial activity of Pd(II) 
complexes with salicylaldehyde-amino acids Schiff bases 
ligands. Chem Pharmaceut Bull 62:12–15. https ://doi.
org/10.1248/cpb.c12-01087 
Rosenberg B, Vancamp L, Trosko JE, Mansour VH (1969) Platinum 
compounds: a new class of potent antitumour agents. Nature 
222:385–386. https ://doi.org/10.1038/22238 5a0
Samota MK, Seth G (2010) Synthesis, characterization, and anti-
microbial activity of palladium(II) and platinum(II) complexes 
with 2-substituted benzoxazole ligands. Heteroatom Chem 
21:44–50. https ://doi.org/10.1002/hc.20578 
Selvakumar B, Rajendiran V, Uma Maheswari P, Stoeckli-Evans H, 
Palaniandavar M (2006) Structures, spectra, and DNA-binding 
properties of mixed ligand copper(II) complexes of iminodi-
acetic acid: the novel role of diimine co-ligands on DNA confor-
mation and hydrolytic and oxidative double strand DNA cleav-
age. J Inorg Biochem 100:316–330. https ://doi.org/10.1016/j.
jinor gbio.2005.11.018
Singh TP, Singh OM (2018) Recent progress in biological activities 
of indole and indole alkaloids. Mini Rev Med Chem 18:9–25. 
https ://doi.org/10.2174/13895 57517 66617 08071 23201 
Sridhar SK, Pandeya SN, De Clercq E (2001) Synthesis and anti-
HIV activity of some isatin derivatives. Boll Chim Farm 
140:302–305
Sztanke K, Maziarka A, Osinka A, Sztanke M (2013) An insight 
into synthetic Schiff bases revealing antiproliferative activi-
ties in vitro. Bioorg Med Chem 21:3648–3666. https ://doi.
org/10.1016/j.bmc.2013.04.037
Tabassum S, Asim A, Khan RA, Hussain Z, Srivastav S, Srikrishna S 
et al (2013) Chiral heterobimetallic complexes targeting human 
DNA-topoisomerase I[small alpha]. Dalton Trans 42:16749–
16761. https ://doi.org/10.1039/C3DT5 1209F 
Theuretzbacher U (2011) Resistance drives antibacterial drug 
development. Curr Opin Pharmacol 11:433–438. https ://doi.
org/10.1016/j.coph.2011.07.008
Verma A, Joshi S, Singh D (2013) Imidazole: having versa-
tile biological activities. J Chem 2013:10. https ://doi.
org/10.1155/2013/32941 2
Wei Q-Y, Xiong J-J, Jiang H, Zhang C, Wen Y (2011) The antimicro-
bial activities of the cinnamaldehyde adducts with amino acids. 
Int J Food Microbiol 150:164–170. https ://doi.org/10.1016/j.
ijfoo dmicr o.2011.07.034
Wiedermann J, Mereiter K, Kirchner K (2006) Palladium imine and 
amine complexes derived from 2-thiophenecarboxaldehyde 
as catalysts for the Suzuki cross-coupling of aryl bromides. J 
Mol Catal A Chem 257:67–72. https ://doi.org/10.1016/j.molca 
ta.2006.04.009
Wilson JJ, Lippard SJ (2014) Synthetic methods for the preparation 
of platinum anticancer complexes. Chem Rev 114:4470–4495. 
https ://doi.org/10.1021/cr400 4314
Yan X, Xu J, Wu X, Zhang Z, Zhang X, Fan Y et al (2015) Protea-
some inhibition and cytostatic effects on human cancer cells by 
pyrazolone-enamines: a combined crystallographic, structural 




Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin 
nephrotoxicity: a review. Am J Med Sci 334:115–124
You Z-L, Shi D-H, Xu C, Zhang Q, Zhu H-L (2008) Schiff base tran-
sition metal complexes as novel inhibitors of xanthine oxidase. 
Eur J Med Chem 43:862–871. https ://doi.org/10.1016/j.ejmec 
h.2007.06.015
Zeng L, Gupta P, Chen Y, Wang E, Ji L, Chao H et al (2017) The 
development of anticancer ruthenium(ii) complexes: from single 
molecule compounds to nanomaterials. Chem Soc Rev 46:5771–
5804. https ://doi.org/10.1039/C7CS0 0195A 
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
View publication stats
